Investors and Media
Document Details
Form
Filing Date
Jan 7, 2026
Document Date
Jan 5, 2026
Form Description
Initial filing by director officer or owner of more than ten percent
Filing Group
3,4,5
Company
4D Molecular Therapeutics
Issuer
4D MOLECULAR THERAPEUTICS, INC.
Filer
SBLENDORIO GLENN